Bone tissue bioprinting for craniofacial reconstruction

Pallab Datta, Veli Ozbolat, Bugra Ayan, Aman Dhawan, Ibrahim T. Ozbolat

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

Craniofacial (CF) tissue is an architecturally complex tissue consisting of both bone and soft tissues with significant patient specific variations. Conditions of congenital abnormalities, tumor resection surgeries, and traumatic injuries of the CF skeleton can result in major deficits of bone tissue. Despite advances in surgical reconstruction techniques, management of CF osseous deficits remains a challenge. Due its inherent versatility, bioprinting offers a promising solution to address these issues. In this review, we present and analyze the current state of bioprinting of bone tissue and highlight how these techniques may be adapted to serve regenerative therapies for CF applications. Biotechnol. Bioeng. 2017;114: 2424–2431.

Original languageEnglish (US)
Pages (from-to)2424-2431
Number of pages8
JournalBiotechnology and bioengineering
Volume114
Issue number11
DOIs
StatePublished - Nov 2017

Fingerprint

Bioprinting
Bone
Tissue
Bone and Bones
Skeleton
Surgery
Wounds and Injuries
Tumors
Neoplasms

All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Bioengineering
  • Applied Microbiology and Biotechnology

Cite this

Datta, Pallab ; Ozbolat, Veli ; Ayan, Bugra ; Dhawan, Aman ; Ozbolat, Ibrahim T. / Bone tissue bioprinting for craniofacial reconstruction. In: Biotechnology and bioengineering. 2017 ; Vol. 114, No. 11. pp. 2424-2431.
@article{ea080d68816f4a8fa9a7d13410fb3ebc,
title = "Bone tissue bioprinting for craniofacial reconstruction",
abstract = "Craniofacial (CF) tissue is an architecturally complex tissue consisting of both bone and soft tissues with significant patient specific variations. Conditions of congenital abnormalities, tumor resection surgeries, and traumatic injuries of the CF skeleton can result in major deficits of bone tissue. Despite advances in surgical reconstruction techniques, management of CF osseous deficits remains a challenge. Due its inherent versatility, bioprinting offers a promising solution to address these issues. In this review, we present and analyze the current state of bioprinting of bone tissue and highlight how these techniques may be adapted to serve regenerative therapies for CF applications. Biotechnol. Bioeng. 2017;114: 2424–2431.",
author = "Pallab Datta and Veli Ozbolat and Bugra Ayan and Aman Dhawan and Ozbolat, {Ibrahim T.}",
year = "2017",
month = "11",
doi = "10.1002/bit.26349",
language = "English (US)",
volume = "114",
pages = "2424--2431",
journal = "Biotechnology and Bioengineering",
issn = "0006-3592",
publisher = "Wiley-VCH Verlag",
number = "11",

}

Bone tissue bioprinting for craniofacial reconstruction. / Datta, Pallab; Ozbolat, Veli; Ayan, Bugra; Dhawan, Aman; Ozbolat, Ibrahim T.

In: Biotechnology and bioengineering, Vol. 114, No. 11, 11.2017, p. 2424-2431.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Bone tissue bioprinting for craniofacial reconstruction

AU - Datta, Pallab

AU - Ozbolat, Veli

AU - Ayan, Bugra

AU - Dhawan, Aman

AU - Ozbolat, Ibrahim T.

PY - 2017/11

Y1 - 2017/11

N2 - Craniofacial (CF) tissue is an architecturally complex tissue consisting of both bone and soft tissues with significant patient specific variations. Conditions of congenital abnormalities, tumor resection surgeries, and traumatic injuries of the CF skeleton can result in major deficits of bone tissue. Despite advances in surgical reconstruction techniques, management of CF osseous deficits remains a challenge. Due its inherent versatility, bioprinting offers a promising solution to address these issues. In this review, we present and analyze the current state of bioprinting of bone tissue and highlight how these techniques may be adapted to serve regenerative therapies for CF applications. Biotechnol. Bioeng. 2017;114: 2424–2431.

AB - Craniofacial (CF) tissue is an architecturally complex tissue consisting of both bone and soft tissues with significant patient specific variations. Conditions of congenital abnormalities, tumor resection surgeries, and traumatic injuries of the CF skeleton can result in major deficits of bone tissue. Despite advances in surgical reconstruction techniques, management of CF osseous deficits remains a challenge. Due its inherent versatility, bioprinting offers a promising solution to address these issues. In this review, we present and analyze the current state of bioprinting of bone tissue and highlight how these techniques may be adapted to serve regenerative therapies for CF applications. Biotechnol. Bioeng. 2017;114: 2424–2431.

UR - http://www.scopus.com/inward/record.url?scp=85030117023&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030117023&partnerID=8YFLogxK

U2 - 10.1002/bit.26349

DO - 10.1002/bit.26349

M3 - Review article

C2 - 28600873

AN - SCOPUS:85030117023

VL - 114

SP - 2424

EP - 2431

JO - Biotechnology and Bioengineering

JF - Biotechnology and Bioengineering

SN - 0006-3592

IS - 11

ER -